Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-82.48 M USD-18.29 M USD-36.91 M USD-10.40 M USD-2.84 M USD-3.64 M USD-5.05 M USD-5.71 M USD-5.71 M USD-3.88 M USD-3.52 M USD-3.23 M USD
Depreciation & Amortization3.25 M USD2.31 M USD986000 USD267000 USD149000 USD147000 USD136000 USD80000 USD68000 USD470851 USD576380 USD685396 USD
Stock-Based Compensation8.97 M USD5.39 M USD3.74 M USD983000 USD386000 USD495000 USD420000 USD404000 USD372000 USD290312 USD205264 USD185987 USD
Capital Expenditures12.75 M USD54.41 M USD1.07 M USD282000 USD381000 USD273000 USD444000 USD337000 USD549000 USD479215 USD133305 USD19029 USD
Cash Flow from Investing41.23 M USD-218.93 M USD24.37 M USD-28.99 M USD-410000 USD-287000 USD401000 USD1.86 M USD1.51 M USD8.76 M USD783660 USD-15.44 M USD
Cash Flow from Financing10.30 M USD289.38 M USD785000 USD28000 USD64.68 M USD994000 USD7.37 M USD521000 USD-9000 USD39000 USD284865 USD23.45 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-95.23 M USD-72.71 M USD-37.98 M USD-10.68 M USD-3.22 M USD-3.91 M USD-5.49 M USD-6.05 M USD-6.26 M USD-4.36 M USD-3.66 M USD-3.25 M USD

Perspective Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics and technologies to treat various diseases, primarily within the oncology sector. Its primary function is to advance research that can lead to practical cancer treatment solutions, potentially impacting patient care significantly. The company engages in developing novel targeted therapies, often collaborating with leading research institutions and utilizing cutting-edge scientific techniques. Perspective Therapeutics Inc. plays a critical role in the healthcare market by addressing unmet medical needs and contributing to the growing demand for personalized medicine approaches. The work undertaken by the company holds substantial importance for the biotech and pharmaceutical industries as it seeks to improve therapeutic outcomes and enhance medical capabilities in combating cancer and other serious illnesses. The company's initiatives not only underscore the importance of biotechnology in advancing healthcare solutions but also highlight the ongoing evolution within the medical research landscape.